Also known as semaglutides, GLP-1 agonists promote metabolic wellness and a healthy body weight
Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, et al
The compound directly addresses the root challenge of overeating
Ozempic works by mimicking the naturally occurring GLP-1 hormone and activating its receptors.[2] This process helps reduce blood sugar levels by stimulating insulin secretion and lowering glucagon release (glucagon signals the liver to release stored glucose into the bloodstream)
It has become the latest food company to shake up its offering to cater to an American market where 30 million people have tried GLP-1 agonist drugs already, a number that could reach 100 million or 40% of the population in the coming years
It can be weakened by factors such as stress, illness, a poor diet, insufficient sleep, or lack of activity